Patents by Inventor Thomas Greiner-Stoeffele

Thomas Greiner-Stoeffele has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240132866
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Application
    Filed: November 22, 2022
    Publication date: April 25, 2024
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Patent number: 11542489
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: January 3, 2023
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Publication number: 20210355472
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Application
    Filed: July 27, 2021
    Publication date: November 18, 2021
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Patent number: 10889809
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: January 12, 2021
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Patent number: 10724008
    Abstract: The invention relates to ketoreductases and the use thereof. The ketoreductases of the invention are particularly useful for enzymatically catalyzing the reduction of ketones to chiral secondary alcohols.
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: July 28, 2020
    Assignee: C-LEcta GmbH
    Inventors: Ramona Schmiedel, Andreas Vogel, Sabrina Koepke, Rico Czaja, Claudia Feller, Hedda Merkens, Kamila Rzeznicka, Daniel Schwarze, Thomas Greiner-Stoeffele, Andreas Petri, Marc Struhalla
  • Publication number: 20200115692
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Application
    Filed: December 2, 2019
    Publication date: April 16, 2020
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Patent number: 10526594
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Grant
    Filed: October 26, 2016
    Date of Patent: January 7, 2020
    Assignee: Roche Diagnostics Operations, Inc.
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Publication number: 20190203191
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Application
    Filed: March 15, 2019
    Publication date: July 4, 2019
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Publication number: 20190062714
    Abstract: The invention relates to ketoreductases and the use thereof. The ketoreductases of the invention are particularly useful for enzymatically catalyzing the reduction of ketones to chiral secondary alcohols.
    Type: Application
    Filed: August 30, 2018
    Publication date: February 28, 2019
    Applicant: C-LEcta GmbH
    Inventors: Ramona Schmiedel, Andreas Vogel, Sabrina Koepke, Rico Czaja, Claudia Feller, Hedda Merkens, Kamila Rzeznicka, Daniel Schwarze, Thomas Greiner-Stoeffele, Andreas Petri, Marc Struhalla
  • Patent number: 10196645
    Abstract: An expression vector including two separately inducible converging promoters P1 and P2, and expression system including such an expression vector and an additional regulator vector, a method of protein expression using such an expression system, and a method of investigating (meta)genome libraries using such an expression system.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: February 5, 2019
    Assignee: c-LEcta GmbH
    Inventors: Thomas Greiner-Stoeffele, Meike Hoffmann, Marc Struhalla, Rico Czaja
  • Patent number: 10093905
    Abstract: The invention relates to ketoreductases and the use thereof. The ketoreductases of the invention are particularly useful for enzymatically catalyzing the reduction of ketones to chiral secondary alcohols.
    Type: Grant
    Filed: April 17, 2015
    Date of Patent: October 9, 2018
    Assignee: C-LEcta GmbH
    Inventors: Ramona Schmiedel, Andreas Vogel, Sabrina Koepke, Rico Czaja, Claudia Feller, Hedda Merkens, Kamila Rzeznicka, Daniel Schwarze, Thomas Greiner-Stoeffele, Andreas Petri, Marc Struhalla
  • Patent number: 9856470
    Abstract: A method for generating a variant library of DNA sequences starting from at least one DNA starting sequence and including the steps: a) selecting at least two mutation sites in the starting sequence; b) dividing the DNA starting sequence into at least two sequence segments such that at least two of these sequence segments each contain at least one of the mutation sites; c) amplifying the sequence segments by polymerase chain reaction using at least five different oligonucleotides, where at (i) least one of the oligonucleotides can attach to each mutation site; (ii) at least two of the oligonucleotides can attach to at least one mutation site, and (iii) mutations are introduced, via mismatch positions, into the PCR amplificates by the oligonucleotides at the mutation sites where at least two mutations are introduced at at least one of the mutation sites; and d) linking the amplificates to give DNA sequences.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: January 2, 2018
    Assignee: c-LEcta GmbH
    Inventors: Thomas Greiner-Stoeffele, Claudia Feller, Marc Struhalla
  • Patent number: 9796994
    Abstract: A method for producing a nuclease of a gram negative bacterium or a nuclease preparation containing a nuclease of a gram negative bacterium including expression of the nuclease in a gram positive bacterium and subsequent secretion of the nuclease, as well as a nuclease or a nuclease preparation that can be obtained by this method.
    Type: Grant
    Filed: February 2, 2012
    Date of Patent: October 24, 2017
    Assignee: c-LEcta GmbH
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Patent number: 9723854
    Abstract: The invention relates to the use of an amidohydrolase for preparing foodstuffs or stimulants.
    Type: Grant
    Filed: June 12, 2008
    Date of Patent: August 8, 2017
    Assignee: C-LECTA GMBH
    Inventors: Thomas Greiner-Stoeffele, Marc Struhalla
  • Publication number: 20170218345
    Abstract: The invention relates to ketoreductases and the use thereof. The ketoreductases of the invention are particularly useful for enzymatically catalyzing the reduction of ketones to chiral secondary alcohols.
    Type: Application
    Filed: April 17, 2015
    Publication date: August 3, 2017
    Applicants: C-LEcta GmbH, C-LEcta GmbH
    Inventors: Ramona Schmiedel, Andreas Vogel, Sabrina Koepke, Rico Czaja, Claudia Feller, Hedda Merkens, Kamila Rzeznicka, Daniel Schwarze, Thomas Greiner-Stoeffele, Andreas Petri, Marc Struhalla
  • Publication number: 20170037390
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Application
    Filed: October 26, 2016
    Publication date: February 9, 2017
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Publication number: 20160194647
    Abstract: An expression vector including two separately inducible converging promoters P1 and P2, and expression system including such an expression vector and an additional regulator vector, a method of protein expression using such an expression system, and a method of investigating (meta)genome libraries using such an expression system.
    Type: Application
    Filed: January 11, 2016
    Publication date: July 7, 2016
    Inventors: Thomas Greiner-Stoeffele, Meike Ballschmitter, Marc Struhalla, Rico Czaja
  • Publication number: 20150166973
    Abstract: The present disclosure provides the sequence of a Paenibacillus polymyxa preproenzyme which is the precursor of a neutral protease, expression thereof in a transformed host organism, and methods for production of the neutral protease, by recombinant means. Further, use of the recombinantly produced neutral protease is disclosed in the field of cell biology, particularly for the purpose of tissue dissociation. The disclosure also includes blends with other proteases. Further disclosed are nucleotide sequences encoding the neutral protease.
    Type: Application
    Filed: January 9, 2015
    Publication date: June 18, 2015
    Inventors: Thomas Greiner-Stoeffele, Stefan Schoenert
  • Patent number: 8916364
    Abstract: The invention relates to a nitrilase having improved activity in the reaction of a nitrile to form the corresponding carboxylic acid, in particular with respect to reacting 2-methylglutaronitrile, 1-(cyanomethyl)cyclohexane-1-carbonitrile, and benzonitrile. The nitrilase according to the invention is related to nitrilase from acidovorax facilis.
    Type: Grant
    Filed: October 12, 2011
    Date of Patent: December 23, 2014
    Assignee: c-LEcta GmbH
    Inventors: Andreas Vogel, Daniel Schwarze, Thomas Greiner-Stoeffele
  • Publication number: 20130288315
    Abstract: The invention relates to a nitrilase having improved activity in the reaction of a nitrile to form the corresponding carboxylic acid, in particular with respect to reacting 2-methylglutaronitrile, 1-(cyanomethyl)cyclohexane-1-carbonitrile, and benzonitrile. The nitrilase according to the invention is related to nitrilase from acidovorax facilis.
    Type: Application
    Filed: October 12, 2011
    Publication date: October 31, 2013
    Applicant: c-LEcta GmbH
    Inventors: Andreas Vogel, Daniel Schwarze, Thomas Greiner-Stoeffele